FYI: Remember when biotech was once about as popular as you could get? Then the stocks peaked in 2015, as growing competition, expiring patents, and potential government efforts to rein in runaway drug prices took their toll. From July 20, 2015, through June 27, 2016, the iShares Nasdaq Biotechnology exchange-traded fund (IBB) dropped nearly 40%. Even after rallying in fits and starts, the group still remains more than 10% below its all-time high.
Regards,
Ted
http://www.cetusnews.com/business/Biotech-Ready-to-Bust-Out.Skn6POtrf.html
